United States · FDA National Drug Code directory
Excedrin Migraine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66715-9749_292c702d-fbca-eda6-e063-6394a90ac866
- Product NDC
- 66715-9749
- Form
- TABLET, FILM COATED
- Composition / generic term
- acetaminophen, aspirin, and caffeine
- Labeler
- Lil' Drug Store Products, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190815
- Source listing expiry
- 20261231
Source-listed ingredients
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
- CAFFEINE — 65 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 POUCH in 1 CARTON (66715-9749-2) / 2 TABLET, FILM COATED in 1 POUCH · 66715-9749-2
- 3 POUCH in 1 CARTON (66715-9749-3) / 2 TABLET, FILM COATED in 1 POUCH · 66715-9749-3
- 30 POUCH in 1 BOX, UNIT-DOSE (66715-9749-8) / 2 TABLET, FILM COATED in 1 POUCH · 66715-9749-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →